1,304
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells

, , , &
Pages 1358-1366 | Received 05 Jun 2014, Accepted 06 Jul 2014, Published online: 14 Jul 2014

References

  • Fukuda K, Abei M, Ugai H, Kawashima R, Seo E, Wakayama M, Murata T, Endo S, Hamada H, Hyodo I, et al. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer. Cancer Gene Ther 2009; 16:126 - 36; http://dx.doi.org/10.1038/cgt.2008.67; PMID: 18818710
  • Huang Q, Zhang X, Wang H, Yan B, Kirkpatrick J, Dewhrist MW, Li CY. A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin Cancer Res 2004; 10:1439 - 45; http://dx.doi.org/10.1158/1078-0432.CCR-03-0122; PMID: 14977847
  • Jounaidi Y, Doloff JC, Waxman DJ. Conditionally replicating adenoviruses for cancer treatment. Curr Cancer Drug Targets 2007; 7:285 - 301; http://dx.doi.org/10.2174/156800907780618301; PMID: 17504125
  • Wirth T, Kühnel F, Kubicka S. Telomerase-dependent gene therapy. Curr Mol Med 2005; 5:243 - 51; http://dx.doi.org/10.2174/1566524053586536; PMID: 15974879
  • Doloff JC, Waxman DJ, Jounaidi Y. Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions. Hum Gene Ther 2008; 19:1383 - 400; http://dx.doi.org/10.1089/hum.2008.056; PMID: 18771358
  • Costantini LC, Bakowska JC, Breakefield XO, Isacson O. Gene therapy in the CNS. Gene Ther 2000; 7:93 - 109; http://dx.doi.org/10.1038/sj.gt.3301119; PMID: 10673714
  • Wang H, Wei F, Zhang J, Wang F, Li H, Chen X, Xie K, Wang Y, Li C, Huang Q. A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy. Tumour Biol 2012; 33:1245 - 53; http://dx.doi.org/10.1007/s13277-012-0374-7; PMID: 22627833
  • Kirn D. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?. Gene Ther 2001; 8:89 - 98; http://dx.doi.org/10.1038/sj.gt.3301377; PMID: 11313778
  • Lee CT, Park KH, Yanagisawa K, Adachi Y, Ohm JE, Nadaf S, Dikov MM, Curiel DT, Carbone DP. Combination therapy with conditionally replicating adenovirus and replication defective adenovirus. Cancer Res 2004; 64:6660 - 5; http://dx.doi.org/10.1158/0008-5472.CAN-04-1200; PMID: 15374981
  • Lee CT, Lee YJ, Kwon SY, Lee J, Kim KI, Park KH, Kang JH, Yoo CG, Kim YW, Han SK, et al. In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27. Cancer Res 2006; 66:372 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-05-1515; PMID: 16397251
  • Moran E. Interaction of adenoviral proteins with pRB and p53. FASEB J 1993; 7:880 - 5; PMID: 8344487
  • Turnell AS, Mymryk JS. Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation. Br J Cancer 2006; 95:555 - 60; http://dx.doi.org/10.1038/sj.bjc.6603304; PMID: 16880778
  • Yang Y, McKerlie C, Lu Z, Wang L, Buchwald M. In vivo potential effects of adenovirus type 5 E1A and E1B on lung carcinogenesis and lymphoproliferative inflammation. J Virol 2008; 82:8105 - 11; http://dx.doi.org/10.1128/JVI.00536-08; PMID: 18524829
  • Lavery DJ, Chen-Kiang S. Adenovirus E1A and E1B genes are regulated posttranscriptionally in human lymphoid cells. J Virol 1990; 64:5349 - 59; PMID: 2145444
  • Ries SJ, Brandts CH. Oncolytic viruses for the treatment of cancer: current strategies and clinical trials. Drug Discov Today 2004; 9:759 - 68; http://dx.doi.org/10.1016/S1359-6446(04)03221-0; PMID: 15450242
  • Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74:957 - 67; http://dx.doi.org/10.1016/0092-8674(93)90719-7; PMID: 8402885
  • White E. Mechanisms of apoptosis regulation by viral oncogenes in infection and tumorigenesis. Cell Death Differ 2006; 13:1371 - 7; http://dx.doi.org/10.1038/sj.cdd.4401941; PMID: 16676007
  • Cross JR, Postigo A, Blight K, Downward J. Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur. Cell Death Differ 2008; 15:997 - 1008; http://dx.doi.org/10.1038/cdd.2008.14; PMID: 18274554
  • Yoon AR, Kim JH, Lee YS, Kim H, Yoo JY, Sohn JH, Park BW, Yun CO. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Hum Gene Ther 2006; 17:379 - 90; http://dx.doi.org/10.1089/hum.2006.17.379; PMID: 16610926
  • Lomonosova E, Subramanian T, Chinnadurai G. Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K. Oncogene 2005; 24:6796 - 808; http://dx.doi.org/10.1038/sj.onc.1208836; PMID: 16007153
  • Matsushita T, Okada T, Inaba T, Mizukami H, Ozawa K, Colosi P. The adenovirus E1A and E1B19K genes provide a helper function for transfection-based adeno-associated virus vector production. J Gen Virol 2004; 85:2209 - 14; http://dx.doi.org/10.1099/vir.0.79940-0; PMID: 15269360
  • Polster BM, Pevsner J, Hardwick JM. Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim Biophys Acta 2004; 1644:211 - 27; http://dx.doi.org/10.1016/j.bbamcr.2003.11.001; PMID: 14996505
  • Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995; 3:207 - 20; http://dx.doi.org/10.1007/BF02789331; PMID: 7552690
  • Ji X, Cheng L, Wei F, Li H, Wang M, Tian Y, Chen X, Wang Y, Wolf F, Li C, et al. Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging. Invest Ophthalmol Vis Sci 2009; 50:5544 - 51; http://dx.doi.org/10.1167/iovs.08-3258; PMID: 19608529

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.